PAM
TMBR

Panagora Asset Management’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

Panagora Asset Management’s Portfolio TMBR Stock Details TMBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-5
Closed -$30K – 2468
2016
Q4 		$30K Hold
5
– – ﹤0.01% 2164
2016
Q3 		$45K Buy
+5
New +$52.7K ﹤0.01% 2132

Other funds holding TMBR

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Panagora Asset Management's TMBR Position: Q1 2017 in Review

Panagora Asset Management sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q1 2017, closing a stake of 5 shares — an estimated $30K sold.

Panagora Asset Management first reported a position in TMBR in Q3 2016 and held it in 2 quarters. The position peaked at $45K in Q3 2016. 17 funds tracked by Wall St. Rank hold TMBR as of Q1 2017.

  • Panagora Asset Management reported no remaining Timber Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Panagora Asset Management sold 5 Timber Pharmaceuticals, Inc. shares in Q1 2017, an estimated $30K.
  • Panagora Asset Management first reported a position in Timber Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
  • Panagora Asset Management's Timber Pharmaceuticals, Inc. position peaked at $45K in Q3 2016.
  • 17 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q1 2017.

Based on Panagora Asset Management's 13F filing for Q1 2017, filed 15 May 2017.